Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database.

Yajie Wang,Yiran Liang,Fangzhou Ye,Dan Luo,Yuhan Jin,Yaming Li,Wenjing Zhao,Bing Chen,Lijuan Wang,Qifeng Yang

Cancer medicine（2023）

引用 1|浏览8

暂无评分

摘要

Histological subtypes are involved in determining the heterogeneity of HER2+ MBC patient prognosis, which is helpful to guide the prognosis prediction and monitoring of HER2+ breast cancer patients in clinics.

查看译文

关键词

metastatic breast cancer,breast cancer,patient prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要